These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 10952326)
21. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy. Retrospective analysis. Otsuka S; Kunieda K; Hirose M; Takeuchi H; Mizutani Y; Nagaya M; Sato G; Kasuya S; Matsutomo K; Noma A Transfusion; 1989; 29(6):544-8. PubMed ID: 2526400 [TBL] [Abstract][Full Text] [Related]
22. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803 [TBL] [Abstract][Full Text] [Related]
23. Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning. Jaime-Pérez JC; Villarreal-Villarreal CD; Salazar-Riojas R; Méndez-Ramírez N; Vázquez-Garza E; Gómez-Almaguer D Biol Blood Marrow Transplant; 2015 Mar; 21(3):526-30. PubMed ID: 25498924 [TBL] [Abstract][Full Text] [Related]
24. Use of non-irradiated blood components in Campath (alemtuzumab)-treated renal transplant patients. Hui YM; Regan F; Willecombe M; Taube D Transfus Med; 2016 Apr; 26(2):138-46. PubMed ID: 26996635 [TBL] [Abstract][Full Text] [Related]
25. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature. O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807 [TBL] [Abstract][Full Text] [Related]
26. Post-transfusion graft-versus-host disease following open heart surgery. Report of six cases. Sakakibara T; Ida T; Mannouji E; Kikuchi T; Tatsuno K; Kawase M; Imai M J Cardiovasc Surg (Torino); 1989; 30(4):687-91. PubMed ID: 2528550 [TBL] [Abstract][Full Text] [Related]
28. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells. Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443 [TBL] [Abstract][Full Text] [Related]
29. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different? Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453 [TBL] [Abstract][Full Text] [Related]
30. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)]. Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455 [TBL] [Abstract][Full Text] [Related]
31. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Wagner FF; Flegel WA Transfusion; 1995 Apr; 35(4):284-91. PubMed ID: 7701545 [TBL] [Abstract][Full Text] [Related]
33. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Leitman SF; Tisdale JF; Bolan CD; Popovsky MA; Klippel JH; Balow JE; Boumpas DT; Illei GG Transfusion; 2003 Dec; 43(12):1667-71. PubMed ID: 14641861 [TBL] [Abstract][Full Text] [Related]
34. [Studies of pathogenicity of GVHD induced by blood transfusion after open heart surgery]. Hisatomi K; Isomura T; Shimada S; Hirano A; Ando F; Ohishi K Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):928-32. PubMed ID: 2796963 [TBL] [Abstract][Full Text] [Related]
35. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury. Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463 [TBL] [Abstract][Full Text] [Related]
36. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. Gorman TE; Julius CJ; Barth RF; Ng A; Kennedy MS; Prior TW; Allen J; Lasky LC Am J Clin Pathol; 2000 May; 113(5):732-7. PubMed ID: 10800407 [TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological features of transfusion-associated graft-versus-host disease]. Otsuka S; Kimura A; Ishizuka T Nihon Rinsho; 1997 Sep; 55(9):2252-8. PubMed ID: 9301285 [TBL] [Abstract][Full Text] [Related]
38. Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation. van der Mast BJ; van den Dorpel MA; Drabbels JJ; Claas FH; Weimar W Clin Transplant; 2003 Oct; 17(5):477-83. PubMed ID: 14703935 [TBL] [Abstract][Full Text] [Related]
39. Graft-versus-host disease: introduction and prospect. Ohto H; Suzuki H; Abe R Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136 [TBL] [Abstract][Full Text] [Related]